Connection

Brent Egan to Male

This is a "connection" page, showing publications Brent Egan has written about Male.
Connection Strength

2.330
  1. Association of Baseline Adherence to Antihypertensive Medications With Adherence After Shelter-in-Place Guidance for COVID-19 Among US Adults. JAMA Netw Open. 2022 12 01; 5(12):e2247787.
    View in: PubMed
    Score: 0.047
  2. Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment Guidelines. Hypertension. 2022 02; 79(2):338-348.
    View in: PubMed
    Score: 0.043
  3. Sociodemographic Determinants of Life's Simple 7: Implications for Achieving Cardiovascular Health and Health Equity Goals. Ethn Dis. 2020; 30(4):637-650.
    View in: PubMed
    Score: 0.040
  4. Nicotine replacement therapy sampling for smoking cessation within primary care: results from a pragmatic cluster randomized clinical trial. Addiction. 2020 07; 115(7):1358-1367.
    View in: PubMed
    Score: 0.038
  5. Habitual protein intake, protein distribution patterns and dietary sources in Irish adults with stratification by sex and age. J Hum Nutr Diet. 2020 08; 33(4):465-476.
    View in: PubMed
    Score: 0.038
  6. A cluster-based approach for integrating clinical management of Medicare beneficiaries with multiple chronic conditions. PLoS One. 2019; 14(6):e0217696.
    View in: PubMed
    Score: 0.037
  7. Improving Hypertension Control in Primary Care With the Measure Accurately, Act Rapidly, and Partner With Patients Protocol. Hypertension. 2018 12; 72(6):1320-1327.
    View in: PubMed
    Score: 0.035
  8. Differences in primary cardiovascular disease prevention between the 2013 and 2016 cholesterol guidelines and impact of the 2017 hypertension guideline in the United States. J Clin Hypertens (Greenwich). 2018 06; 20(6):991-1000.
    View in: PubMed
    Score: 0.034
  9. Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results. J Clin Hypertens (Greenwich). 2018 01; 20(1):79-87.
    View in: PubMed
    Score: 0.033
  10. Effects of a Six-Month Multi-Ingredient Nutrition Supplement Intervention of Omega-3 Polyunsaturated Fatty Acids, vitamin D, Resveratrol, and Whey Protein on Cognitive Function in Older Adults: A Randomised, Double-Blind, Controlled Trial. J Prev Alzheimers Dis. 2018; 5(3):175-183.
    View in: PubMed
    Score: 0.033
  11. Cholesterol Control Among Uninsured Adults Did Not Improve From 2001-2004 to 2009-2012 as Disparities With Both Publicly and Privately Insured Adults Doubled. J Am Heart Assoc. 2017 Nov 02; 6(11).
    View in: PubMed
    Score: 0.033
  12. Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012. Hypertension. 2017 08; 70(2):275-284.
    View in: PubMed
    Score: 0.032
  13. Opportunities for improving cardiovascular health outcomes in adults younger than 65?years with guideline-recommended statin therapy. J Clin Hypertens (Greenwich). 2017 Sep; 19(9):850-860.
    View in: PubMed
    Score: 0.032
  14. Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2017 Mar; 19(3):241-249.
    View in: PubMed
    Score: 0.031
  15. 2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals. J Am Heart Assoc. 2016 08 19; 5(8).
    View in: PubMed
    Score: 0.030
  16. Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines. Hypertension. 2016 08; 68(2):318-23.
    View in: PubMed
    Score: 0.030
  17. Aldosterone Antagonists or Renin-Guided Therapy for Treatment-Resistant Hypertension: A Comparative Effectiveness Pilot Study in Primary Care. Am J Hypertens. 2016 08; 29(8):976-83.
    View in: PubMed
    Score: 0.029
  18. Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2016 08; 18(8):817-24.
    View in: PubMed
    Score: 0.029
  19. Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network. Ther Adv Cardiovasc Dis. 2016 Apr; 10(2):56-66.
    View in: PubMed
    Score: 0.029
  20. Weight Loss Pharmacotherapy: Brief Summary of the Clinical Literature and Comments on Racial Differences. Ethn Dis. 2015 Nov 05; 25(4):511-4.
    View in: PubMed
    Score: 0.029
  21. Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacks. J Clin Hypertens (Greenwich). 2015 Apr; 17(4):252-9.
    View in: PubMed
    Score: 0.027
  22. Effectiveness of a tailored behavioral intervention to improve hypertension control. Hypertension. 2015 Feb; 65(2):273-5.
    View in: PubMed
    Score: 0.027
  23. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation. 2014 Nov 04; 130(19):1692-9.
    View in: PubMed
    Score: 0.027
  24. The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010. Hypertension. 2014 Nov; 64(5):997-1004.
    View in: PubMed
    Score: 0.026
  25. Diabetes and age-related demographic differences in risk factor control. J Am Soc Hypertens. 2014 Jun; 8(6):394-404.
    View in: PubMed
    Score: 0.026
  26. Closing the gap in hypertension control between younger and older adults: National Health and Nutrition Examination Survey (NHANES) 1988 to 2010. Circulation. 2014 May 20; 129(20):2052-61.
    View in: PubMed
    Score: 0.026
  27. Response to Comment on optimal treatment for resistant hypertension: the missing data on pulse wave velocity. Hypertension. 2014 Mar; 63(3):e17-8.
    View in: PubMed
    Score: 0.025
  28. Prediction of incident hypertension. Health implications of data mining in the 'Big Data' era. J Hypertens. 2013 Nov; 31(11):2123-4.
    View in: PubMed
    Score: 0.025
  29. Collectrin, an X-linked, angiotensin converting enzyme 2 homolog, causes hypertension in a rat strain through gene-gene and gene-environment interactions: relevance to human hypertension. Circulation. 2013 Oct 15; 128(16):1727-8.
    View in: PubMed
    Score: 0.025
  30. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. Hypertension. 2013 Oct; 62(4):691-7.
    View in: PubMed
    Score: 0.024
  31. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010. Circulation. 2013 Jul 02; 128(1):29-41.
    View in: PubMed
    Score: 0.024
  32. Plasma lipidomic profile signature of hypertension in mexican american families. Hypertension. 2013 Sep; 62(3):453-4.
    View in: PubMed
    Score: 0.024
  33. Associations among environmental supports, physical activity, and blood pressure in African-American adults in the PATH trial. Soc Sci Med. 2013 Jun; 87:108-15.
    View in: PubMed
    Score: 0.024
  34. Sympathetic activation and endothelial dysfunction as therapeutic targets in obesity-related hypertension. J Hypertens. 2013 Feb; 31(2):259-60.
    View in: PubMed
    Score: 0.024
  35. Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals. J Clin Hypertens (Greenwich). 2013 Mar; 15(3):154-61.
    View in: PubMed
    Score: 0.023
  36. Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999-2008. J Clin Hypertens (Greenwich). 2012 Nov; 14(11):751-9.
    View in: PubMed
    Score: 0.023
  37. Achievement of cardiometabolic goals in aware hypertensive patients in Spain: implications for population health. Hypertension. 2012 Oct; 60(4):891-3.
    View in: PubMed
    Score: 0.023
  38. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012 Jun; 59(6):1124-31.
    View in: PubMed
    Score: 0.022
  39. Demographic differences in the treatment and control of glucose in type 2 diabetic patients: implications for health care practice. Ethn Dis. 2012; 22(1):29-37.
    View in: PubMed
    Score: 0.022
  40. Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011 Oct; 58(4):579-87.
    View in: PubMed
    Score: 0.021
  41. Renal sympathetic denervation: a novel intervention for resistant hypertension, insulin resistance, and sleep apnea. Hypertension. 2011 Oct; 58(4):542-3.
    View in: PubMed
    Score: 0.021
  42. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011 Aug 30; 124(9):1046-58.
    View in: PubMed
    Score: 0.021
  43. Impacting population cardiovascular health through a community-based practice network: update on an ASH-supported collaborative. J Clin Hypertens (Greenwich). 2011 Aug; 13(8):543-50.
    View in: PubMed
    Score: 0.021
  44. Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets? Curr Opin Cardiol. 2011 Jul; 26(4):300-7.
    View in: PubMed
    Score: 0.021
  45. Prehypertension: an opportunity for a new public health paradigm. Cardiol Clin. 2010 Nov; 28(4):561-9.
    View in: PubMed
    Score: 0.020
  46. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010 May 26; 303(20):2043-50.
    View in: PubMed
    Score: 0.020
  47. Does dark chocolate have a role in the prevention and management of hypertension?: commentary on the evidence. Hypertension. 2010 Jun; 55(6):1289-95.
    View in: PubMed
    Score: 0.019
  48. Antihypertensive medication prescribing patterns in a university teaching hospital. J Clin Hypertens (Greenwich). 2010 Apr; 12(4):246-52.
    View in: PubMed
    Score: 0.019
  49. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010 Apr; 24(4):237-46.
    View in: PubMed
    Score: 0.018
  50. Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans. J Hum Hypertens. 2009 Dec; 23(12):826-35.
    View in: PubMed
    Score: 0.018
  51. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009 Jul; 22(7):792-801.
    View in: PubMed
    Score: 0.018
  52. Sleep-disordered breathing and blood pressure in children. Hypertension. 2008 Nov; 52(5):807.
    View in: PubMed
    Score: 0.017
  53. Concordance between self-reported heights and weights and current and ideal body images in young adult African American men and women. Ethn Dis. 2007; 17(4):617-23.
    View in: PubMed
    Score: 0.015
  54. Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network. J Clin Hypertens (Greenwich). 2006 Dec; 8(12):879-86.
    View in: PubMed
    Score: 0.015
  55. Autonomic dysregulation and the metabolic syndrome: pathologic partners in an emerging global pandemic. Arq Bras Cardiol. 2006 Oct; 87(4):538-47.
    View in: PubMed
    Score: 0.015
  56. Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension. J Hypertens. 2006 Jul; 24(7):1383-9.
    View in: PubMed
    Score: 0.015
  57. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006 Mar; 47(3):345-51.
    View in: PubMed
    Score: 0.014
  58. Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. J Clin Hypertens (Greenwich). 2005 Dec; 7(12):705-11; quiz 712-3.
    View in: PubMed
    Score: 0.014
  59. Ethnic differences in the treatment and control of hypertension in patients with diabetes. J Clin Hypertens (Greenwich). 2005 Aug; 7(8):445-54.
    View in: PubMed
    Score: 0.014
  60. Prevalence, treatment, and control of chest pain syndromes and associated risk factors in hypertensive patients. Am J Hypertens. 2005 Aug; 18(8):1026-32.
    View in: PubMed
    Score: 0.014
  61. Gender- and age-related differences in treatment and control of cardiovascular risk factors among high-risk patients with angina. J Clin Hypertens (Greenwich). 2005 Jul; 7(7):386-94.
    View in: PubMed
    Score: 0.014
  62. Prehypertension and cardiovascular morbidity. Ann Fam Med. 2005 Jul-Aug; 3(4):294-9.
    View in: PubMed
    Score: 0.014
  63. Ethnic differences in older americans: awareness, knowledge, and beliefs about hypertension. Am J Hypertens. 2005 Jul; 18(7):972-9.
    View in: PubMed
    Score: 0.014
  64. Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites. Arch Intern Med. 2005 May 09; 165(9):1041-7.
    View in: PubMed
    Score: 0.014
  65. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. Am J Hypertens. 2005 Jan; 18(1):3-12.
    View in: PubMed
    Score: 0.013
  66. Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients. Ethn Dis. 2005; 15(1):11-6.
    View in: PubMed
    Score: 0.013
  67. Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients. Ethn Dis. 2005; 15(1):25-32.
    View in: PubMed
    Score: 0.013
  68. Prehypertension and mortality in a nationally representative cohort. Am J Cardiol. 2004 Dec 15; 94(12):1496-500.
    View in: PubMed
    Score: 0.013
  69. Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL. Curr Med Res Opin. 2004 Dec; 20(12):1909-17.
    View in: PubMed
    Score: 0.013
  70. A systematic approach to managing hypertension and the metabolic syndrome in primary care. South Med J. 2004 Oct; 97(10):932-8.
    View in: PubMed
    Score: 0.013
  71. Lipids enhance alpha1-adrenoceptor pressor sensitivity in patients with chronic kidney disease. Am J Kidney Dis. 2004 Sep; 44(3):446-54.
    View in: PubMed
    Score: 0.013
  72. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. Am J Hypertens. 2004 Jun; 17(6):477-82.
    View in: PubMed
    Score: 0.013
  73. A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):18-25.
    View in: PubMed
    Score: 0.013
  74. An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):26-31; quiz 32-3.
    View in: PubMed
    Score: 0.013
  75. Other important applications for beta-blockers in high-risk patients. Postgrad Med. 2003 Dec; 114(6 Suppl Role):35-48.
    View in: PubMed
    Score: 0.012
  76. Cardiovascular risk factor control and treatment patterns in primary care. Manag Care Interface. 2003 Nov; 16(11):21-6.
    View in: PubMed
    Score: 0.012
  77. Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003 Mar 24; 163(6):681-7.
    View in: PubMed
    Score: 0.012
  78. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension. 2003 Mar; 41(3):422-30.
    View in: PubMed
    Score: 0.012
  79. Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects. Am J Hypertens. 2003 Jan; 16(1):67-71.
    View in: PubMed
    Score: 0.012
  80. Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins. Hypertension. 2001 Oct; 38(4):858-63.
    View in: PubMed
    Score: 0.011
  81. Taurine attenuates LPS-induced rolling and adhesion in rat microcirculation. J Surg Res. 2001 Feb; 95(2):85-91.
    View in: PubMed
    Score: 0.010
  82. The hypertension initiative of South Carolina. Promoting cardiovascular health through better blood pressure control. J S C Med Assoc. 2001 Feb; 97(2):57-62.
    View in: PubMed
    Score: 0.010
  83. Acute physical and mental stress resulted in an increase in fatty acids, norepinephrine, and hemodynamic changes in normal individuals: A possible pathophysiological mechanism for hypertension-Pilot study. J Clin Hypertens (Greenwich). 2021 04; 23(4):888-894.
    View in: PubMed
    Score: 0.010
  84. Efficacy of a church-based intervention on cardiovascular risk reduction. Ethn Dis. 2001; 11(4):817-22.
    View in: PubMed
    Score: 0.010
  85. Five-year follow-up of patients treated with intra-dermal botulinum toxin for axillary hyperhidrosis. Ir J Med Sci. 2020 Aug; 189(3):1023-1026.
    View in: PubMed
    Score: 0.010
  86. Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethn Dis. 2000; 10(1):17-23.
    View in: PubMed
    Score: 0.010
  87. The dominant role of systolic hypertension as a vascular risk factor: evidence from the southeastern United States. Am J Med Sci. 1999 Dec; 318(6):365-8.
    View in: PubMed
    Score: 0.009
  88. Relationship between 'on-treatment platelet reactivity', shear stress, and micro-embolic signals in asymptomatic and symptomatic carotid stenosis. J Neurol. 2020 Jan; 267(1):168-184.
    View in: PubMed
    Score: 0.009
  89. Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity. Hypertension. 1998 Oct; 32(4):693-8.
    View in: PubMed
    Score: 0.009
  90. Fatty acids augment endothelium-dependent dilation in hand veins by a cyclooxygenase-dependent mechanism. Hypertension. 1997 Dec; 30(6):1634-9.
    View in: PubMed
    Score: 0.008
  91. Fatty acids, not insulin, modulate alpha1-adrenergic reactivity in dorsal hand veins. Hypertension. 1997 Nov; 30(5):1150-5.
    View in: PubMed
    Score: 0.008
  92. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes. J Neurol Sci. 2017 Apr 15; 375:404-410.
    View in: PubMed
    Score: 0.008
  93. Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis. Hypertension. 1996 Aug; 28(2):228-37.
    View in: PubMed
    Score: 0.008
  94. Fatty acids enhance neurovascular reflex responses by effects on alpha 1-adrenoceptors. Am J Physiol. 1996 Jun; 270(6 Pt 2):R1340-6.
    View in: PubMed
    Score: 0.007
  95. Abnormalities of Anthropometric, Hemodynamic, and Autonomic Variables in Offspring of Hypertensive Parents. J Clin Hypertens (Greenwich). 2016 09; 18(9):942-8.
    View in: PubMed
    Score: 0.007
  96. Orthopaedic complications following cardiac transplantation. Ir Med J. 1996 Jan-Feb; 89(1):26-7.
    View in: PubMed
    Score: 0.007
  97. The Results of the "Positive Action for Today's Health" (PATH) Trial for Increasing Walking and Physical Activity in Underserved African-American Communities. Ann Behav Med. 2015 Jun; 49(3):398-410.
    View in: PubMed
    Score: 0.007
  98. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension. 1995 Apr; 25(4 Pt 2):774-8.
    View in: PubMed
    Score: 0.007
  99. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015 May; 8(3):235-43.
    View in: PubMed
    Score: 0.007
  100. Chaos to complexity: leveling the playing field for measuring value in primary care. J Eval Clin Pract. 2017 Apr; 23(2):430-438.
    View in: PubMed
    Score: 0.007
  101. Additive effects of obesity and hypertension to limit venous volume. Am J Physiol. 1995 Feb; 268(2 Pt 2):R562-8.
    View in: PubMed
    Score: 0.007
  102. Is there a role for dietary fish oil in the treatment of hypertension? J Hum Hypertens. 1994 Dec; 8(12):895-905.
    View in: PubMed
    Score: 0.007
  103. Antihypertensive medication persistence 1-year post-stroke hospitalization. J Clin Hypertens (Greenwich). 2014 Dec; 16(12):869-74.
    View in: PubMed
    Score: 0.007
  104. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens. 1994 Oct; 7(10 Pt 1):886-93.
    View in: PubMed
    Score: 0.007
  105. Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives. J Hypertens. 1994 Sep; 12(9):1061-7.
    View in: PubMed
    Score: 0.007
  106. Elevated blood pressures in obese young men with mild hypertension are sustained during the day and night. Am J Hypertens. 1994 Jul; 7(7 Pt 1):609-14.
    View in: PubMed
    Score: 0.007
  107. Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2014 Jul; 261(7):1405-12.
    View in: PubMed
    Score: 0.006
  108. The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child. Pediatr Nephrol. 2014 Aug; 29(8):1403-9.
    View in: PubMed
    Score: 0.006
  109. In prehypertension leukocytosis is associated with body mass index but not with blood pressure or incident hypertension. J Hypertens. 2014 Feb; 32(2):251-9.
    View in: PubMed
    Score: 0.006
  110. Decreased heart rate variability is associated with increased transcranial Doppler velocities in children with sickle cell disease. Ethn Dis. 2014; 24(4):451-5.
    View in: PubMed
    Score: 0.006
  111. Ketanserin's sympatholytic and serotonin2-receptor blocking actions precede the hypotensive effects. J Hum Hypertens. 1994 Jan; 8(1):59-64.
    View in: PubMed
    Score: 0.006
  112. Insulin levels are similar in obese salt-sensitive and salt-resistant hypertensive subjects. Hypertension. 1994 Jan; 23(1 Suppl):I1-7.
    View in: PubMed
    Score: 0.006
  113. The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion. Clinics (Sao Paulo). 2013 Dec; 68(12):1495-501.
    View in: PubMed
    Score: 0.006
  114. Views of parents in four European countries about the effect of food on the mental performance of primary school children. Eur J Clin Nutr. 2014 Jan; 68(1):32-7.
    View in: PubMed
    Score: 0.006
  115. Epithelial sodium channel inhibition by amiloride on blood pressure and cardiovascular disease risk in young prehypertensives. J Clin Hypertens (Greenwich). 2014 Jan; 16(1):47-53.
    View in: PubMed
    Score: 0.006
  116. Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone. J Hypertens. 1993 Oct; 11(10):1113-20.
    View in: PubMed
    Score: 0.006
  117. Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension. 1993 Oct; 22(4):584-90.
    View in: PubMed
    Score: 0.006
  118. Blood pressure reclassification in adolescents based on repeat clinic blood pressure measurements. J Clin Hypertens (Greenwich). 2013 Oct; 15(10):717-22.
    View in: PubMed
    Score: 0.006
  119. Effects of enalapril on the hyperinsulinemic response to severe salt restriction in obese young men with mild systemic hypertension. Am J Cardiol. 1993 Jul 01; 72(1):53-7.
    View in: PubMed
    Score: 0.006
  120. Increased platelet activation in early symptomatic vs. asymptomatic carotid stenosis and relationship with microembolic status: results from the Platelets and Carotid Stenosis Study. J Thromb Haemost. 2013 Jul; 11(7):1407-16.
    View in: PubMed
    Score: 0.006
  121. Increased prevalence of abnormal signal-averaged electrocardiograms in older patients who have hypertension with low diastolic blood pressure. Am Heart J. 1993 Jun; 125(6):1698-703.
    View in: PubMed
    Score: 0.006
  122. Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):404-12.
    View in: PubMed
    Score: 0.006
  123. Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. Am J Cardiol. 1992 Nov 15; 70(15):1347-52.
    View in: PubMed
    Score: 0.006
  124. Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2013 Feb; 260(2):590-6.
    View in: PubMed
    Score: 0.006
  125. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol. 2012 Oct 02; 60(14):1271-7.
    View in: PubMed
    Score: 0.006
  126. Hypertension, diuretics, and coronary heart disease: a case of apples and oranges, reciprocal prejudice, and a partially-clad emperor? Am J Hypertens. 1992 Sep; 5(9):665-6.
    View in: PubMed
    Score: 0.006
  127. Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? J Clin Hypertens (Greenwich). 2012 Jul; 14(7):415-21.
    View in: PubMed
    Score: 0.006
  128. Cardiovascular risk factors, clustering and complications in overweight young men. Med Sect Proc. 1992; 107-15.
    View in: PubMed
    Score: 0.005
  129. NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men. Am J Hypertens. 1991 Dec; 4(12 Pt 1):924-31.
    View in: PubMed
    Score: 0.005
  130. Popliteo-pedal bypass surgery for critical limb ischemia. Ir J Med Sci. 2011 Dec; 180(4):829-35.
    View in: PubMed
    Score: 0.005
  131. Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients. J Clin Hypertens (Greenwich). 2011 Oct; 13(10):731-8.
    View in: PubMed
    Score: 0.005
  132. Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men. Relationship to salt-sensitivity status. Am J Hypertens. 1991 May; 4(5 Pt 1):416-21.
    View in: PubMed
    Score: 0.005
  133. Measuring the impact of a continuing medical education program on patient blood pressure. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):517-22.
    View in: PubMed
    Score: 0.005
  134. Comparative effects of overweight on cardiovascular risk in younger versus older men. Am J Cardiol. 1991 Feb 01; 67(4):248-52.
    View in: PubMed
    Score: 0.005
  135. Potential deleterious impact of dietary salt restriction on cardiovascular risk factors. Klin Wochenschr. 1991; 69 Suppl 25:45-50.
    View in: PubMed
    Score: 0.005
  136. Cardiovascular disease risk factor clustering among African American adults. Ethn Dis. 2011; 21(2):129-34.
    View in: PubMed
    Score: 0.005
  137. Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial. Cardiovasc Ther. 2010 Dec; 28(6):344-9.
    View in: PubMed
    Score: 0.005
  138. Attitudes and practices of resident physicians regarding hypertension in the inpatient setting. J Clin Hypertens (Greenwich). 2010 Sep; 12(9):698-705.
    View in: PubMed
    Score: 0.005
  139. An overview of the "Positive Action for Today's Health" (PATH) trial for increasing walking in low income, ethnic minority communities. Contemp Clin Trials. 2010 Nov; 31(6):624-33.
    View in: PubMed
    Score: 0.005
  140. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug; 28(8):1761-9.
    View in: PubMed
    Score: 0.005
  141. Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens. 2010 Jan-Feb; 4(1):32-41.
    View in: PubMed
    Score: 0.005
  142. Importance of overweight in studies of left ventricular hypertrophy and diastolic function in mild systemic hypertension. Am J Cardiol. 1989 Oct 01; 64(12):752-5.
    View in: PubMed
    Score: 0.005
  143. Regional hemodynamic abnormalities in overweight men. Focus on alpha-adrenergic vascular responses. Am J Hypertens. 1989 Jun; 2(6 Pt 1):428-34.
    View in: PubMed
    Score: 0.005
  144. Erythrocyte water, Na+-K+ cotransport, and forearm vascular function in humans. Hypertension. 1988 Aug; 12(2):199-203.
    View in: PubMed
    Score: 0.004
  145. Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension. Am J Hypertens. 1988 Jul; 1(3 Pt 3):324S-330S.
    View in: PubMed
    Score: 0.004
  146. An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY). J Clin Hypertens (Greenwich). 2008 Jun; 10(6):436-42.
    View in: PubMed
    Score: 0.004
  147. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens. 2008 Mar; 26(3):589-99.
    View in: PubMed
    Score: 0.004
  148. Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM). Ann Fam Med. 2008 Mar-Apr; 6(2):100-6.
    View in: PubMed
    Score: 0.004
  149. Vascular structure enhances regional resistance responses in mild essential hypertension. J Hypertens. 1988 Jan; 6(1):41-8.
    View in: PubMed
    Score: 0.004
  150. Differences in cardiovascular disease mortality associated with body mass between Black and White persons. Am J Public Health. 2008 Jan; 98(1):63-6.
    View in: PubMed
    Score: 0.004
  151. Use of statins and blood pressure. Am J Hypertens. 2007 Sep; 20(9):937-41.
    View in: PubMed
    Score: 0.004
  152. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest. 1987 Sep; 80(3):812-7.
    View in: PubMed
    Score: 0.004
  153. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med. 2007 Mar 12; 167(5):502-6.
    View in: PubMed
    Score: 0.004
  154. The effect of extended-release metoprolol succinate on C-reactive protein levels in persons with hypertension. J Clin Hypertens (Greenwich). 2006 Apr; 8(4):257-60.
    View in: PubMed
    Score: 0.004
  155. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006 Apr 20; 354(16):1685-97.
    View in: PubMed
    Score: 0.004
  156. Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. Health Place. 2007 Mar; 13(1):179-87.
    View in: PubMed
    Score: 0.004
  157. Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number. Clin Pharmacol Ther. 1985 Nov; 38(5):519-24.
    View in: PubMed
    Score: 0.004
  158. Arterial compression of the retro-olivary sulcus of the medulla in essential hypertension: a multivariate analysis. J Hypertens. 2005 Nov; 23(11):2027-31.
    View in: PubMed
    Score: 0.004
  159. Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study. Am J Hypertens. 2005 Jul; 18(7):980-5.
    View in: PubMed
    Score: 0.003
  160. Methods for measuring vascular and nonvascular alpha-receptor sensitivity in humans. J Cardiovasc Pharmacol. 1985; 7 Suppl 6:S153-8.
    View in: PubMed
    Score: 0.003
  161. Role of cardiopulmonary mechanoreceptors in ADH release in normal humans. Hypertension. 1984 Nov-Dec; 6(6 Pt 1):832-6.
    View in: PubMed
    Score: 0.003
  162. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich). 2004 Oct; 6(10):562-8.
    View in: PubMed
    Score: 0.003
  163. Trial of preventing hypertension: design and 2-year progress report. Hypertension. 2004 Aug; 44(2):146-51.
    View in: PubMed
    Score: 0.003
  164. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol. 2003 Dec 01; 92(11):1335-9.
    View in: PubMed
    Score: 0.003
  165. Role of cardiovascular receptors on the neural regulation of renin release in normal men. Hypertension. 1983 Sep-Oct; 5(5):779-86.
    View in: PubMed
    Score: 0.003
  166. Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. Am J Hypertens. 2003 May; 16(5 Pt 1):331-6.
    View in: PubMed
    Score: 0.003
  167. Associations between birth weight and antihypertensive medication in black and white medicaid recipients. Hypertension. 2002 Jan; 39(1):179-83.
    View in: PubMed
    Score: 0.003
  168. Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans. J Clin Hypertens (Greenwich). 2001 Jan-Feb; 3(1):29-31.
    View in: PubMed
    Score: 0.003
  169. Vascular compression of the rostral ventrolateral medulla in sympathetic mediated essential hypertension. Hypertension. 2000 Jul; 36(1):78-82.
    View in: PubMed
    Score: 0.002
  170. Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States. Arch Intern Med. 2000 May 22; 160(10):1472-6.
    View in: PubMed
    Score: 0.002
  171. Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Am J Med Sci. 1999 Dec; 318(6):357-64.
    View in: PubMed
    Score: 0.002
  172. Impact of nativity and race on "Stroke Belt" mortality. Hypertension. 1999 Jul; 34(1):57-62.
    View in: PubMed
    Score: 0.002
  173. A preliminary report of mortality patterns among foundry workers. J Environ Pathol Toxicol. 1979 May-Jun; 2(5):259-72.
    View in: PubMed
    Score: 0.002
  174. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun; 60(5-6):401-5.
    View in: PubMed
    Score: 0.002
  175. Management and outcome of acute myocardial infarction in older patients in the thrombolytic era. J Am Geriatr Soc. 1999 Mar; 47(3):291-4.
    View in: PubMed
    Score: 0.002
  176. Aldosterone in obesity. Endocr Res. 1998 Aug-Nov; 24(3-4):789-96.
    View in: PubMed
    Score: 0.002
  177. Commun-I-Care: experience in the first four years. J S C Med Assoc. 1998 Jul; 94(7):318-22.
    View in: PubMed
    Score: 0.002
  178. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci. 1997 Apr; 313(4):195-209.
    View in: PubMed
    Score: 0.002
  179. Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients. Am J Hypertens. 1997 Jan; 10(1):68-76.
    View in: PubMed
    Score: 0.002
  180. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension. 1996 Jul; 28(1):120-6.
    View in: PubMed
    Score: 0.002
  181. Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer. J Clin Oncol. 1996 May; 14(5):1617-25.
    View in: PubMed
    Score: 0.002
  182. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension. 1995 Jul; 26(1):186-92.
    View in: PubMed
    Score: 0.002
  183. Effect of circulating epinephrine on platelet function and hematocrit. Hypertension. 1995 May; 25(5):1096-105.
    View in: PubMed
    Score: 0.002
  184. Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans. Hypertension. 1995 Jan; 25(1):30-6.
    View in: PubMed
    Score: 0.002
  185. Sensitization of human alpha 1- and alpha 2-adrenergic venous responses by guanadrel sulfate. Clin Pharmacol Ther. 1990 Nov; 48(5):537-43.
    View in: PubMed
    Score: 0.001
  186. Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med. 1990 Feb 15; 112(4):270-7.
    View in: PubMed
    Score: 0.001
  187. Congenital pernicious anemia: effects on growth, brain, and absorption of B12. Pediatrics. 1968 Jul; 42(1):149-56.
    View in: PubMed
    Score: 0.001
  188. Anger and anxiety in borderline hypertension. Psychosom Med. 1986 Mar-Apr; 48(3-4):242-8.
    View in: PubMed
    Score: 0.001
  189. Cardiopulmonary mechanoreceptors and renin release in humans. Fed Proc. 1983 Jul; 42(10):2703-8.
    View in: PubMed
    Score: 0.001
  190. Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans. Hypertension. 1983 Mar-Apr; 5(2 Pt 2):I184-91.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.